An order has been signed to speed up the review of certain psychedelics, including ibogaine. The move is reportedly related to their potential use for mental health treatment, with some advocates expressing support. It is unclear if other actions were taken at the same time, as reports also mention an extension of surveillance powers, but the connection between the two is not specified.